Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Wada

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Modern Rheumatology|May 19, 2010
Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexateYasuharu Nakashima, Masakazu Kondo, Hiroshi Harada, et al.
Hiroshima Journal of Medical Sciences|April 23, 2013
The valproate serum level in maintenance therapy for bipolar disorder in JapanAkihiko Machino, Hiroaki Jitsuiki, Yasumasa Okamoto, et al.
The Journal of Clinical Psychiatry|December 19, 2019
Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk FactorsKotaro Hatta, Yasuhiro Kishi, Ken Wada, et al.
Modern Rheumatology|March 6, 2014
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered dataYasuharu Nakashima, Masakazu Kondo, Takaaki Fukuda, et al.
Modern Rheumatology|April 9, 2013
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered dataYasuharu Nakashima, Masakazu Kondo, Takaaki Fukuda, et al.
Modern Rheumatology|October 4, 2019
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practiceYasuharu Nakashima, Masakazu Kondo, Eisuke Shono, et al.
The Journal of ECT|February 25, 2025
Multicenter Observational Study of Electroconvulsive Therapy in JapanTakeshi Sakayori, Ken Wada, Minoru Takebayashi, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Modern Rheumatology|May 19, 2010
Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexateYasuharu Nakashima, Masakazu Kondo, Hiroshi Harada, et al.
Hiroshima Journal of Medical Sciences|April 23, 2013
The valproate serum level in maintenance therapy for bipolar disorder in JapanAkihiko Machino, Hiroaki Jitsuiki, Yasumasa Okamoto, et al.
The Journal of Clinical Psychiatry|December 19, 2019
Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk FactorsKotaro Hatta, Yasuhiro Kishi, Ken Wada, et al.
Modern Rheumatology|March 6, 2014
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered dataYasuharu Nakashima, Masakazu Kondo, Takaaki Fukuda, et al.
Modern Rheumatology|April 9, 2013
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered dataYasuharu Nakashima, Masakazu Kondo, Takaaki Fukuda, et al.
Modern Rheumatology|October 4, 2019
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practiceYasuharu Nakashima, Masakazu Kondo, Eisuke Shono, et al.
The Journal of ECT|February 25, 2025
Multicenter Observational Study of Electroconvulsive Therapy in JapanTakeshi Sakayori, Ken Wada, Minoru Takebayashi, et al.
Pageof 5